Transactions
May 3, 2017
Tocagen closes $98.7M IPO with counsel from Cooley, Latham & Watkins
Tocagen sold 9.775 million shares of its common stock at $10 each, including 1.275 million shares bought by the underwriting syndicate as it exercised its over-allotment option.
Cooley LLP advised Tocagen Inc., a developer of products that aim to treat cancer, in its initial public offering. Tocagen announced that the deal closed on April 19.
Tocagen sold 9.775 million shares of its common stock at $10 each, including 1.275 million shares bought by the underwriting syndicate as it exercised its over-allotment option. The company said the offering raised about $97.8 million in gross proceeds before deducting the underwriting discount and other estimated exp...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In